Literature DB >> 27416841

Can the Heterosexual HIV Epidemic be Eliminated in South Africa Using Combination Prevention? A Modeling Analysis.

Nadia N Abuelezam, Alethea W McCormick, Thomas Fussell, Abena N Afriyie, Robin Wood, Victor DeGruttola, Kenneth A Freedberg, Marc Lipsitch, George R Seage.   

Abstract

Little is known about how combining efficacious interventions for human immunodeficiency virus (HIV) prevention could lead to HIV elimination. We used an agent-based simulation model, the HIV calibrated dynamic model, to assess the potential for HIV elimination in South Africa. We examined several scenarios (from continuation of the current status quo to perfect achievement of targets) with differing combinations of male condom use, adult male circumcision, HIV testing, and early antiretroviral therapy (ART). We varied numerous parameters, including the proportion of adult males circumcised, the frequency of condom use during sex acts, acceptance of HIV testing, linkage to health care, criteria for ART initiation, ART viral suppression rates, and loss to follow-up. Maintaining current levels of combination prevention would lead to increasing HIV incidence and prevalence in South Africa, while the perfect combination scenario was projected to eliminate HIV on a 50-year time scale from 2013 to 2063. Perfecting testing and treatment, without changing condom use or circumcision rates, resulted in an 89% reduction in HIV incidence but not elimination. Universal adult male circumcision alone resulted in a 21% incidence reduction within 20 years. Substantial decreases in HIV incidence are possible from sufficient uptake of both primary prevention and ART, but with continuation of the status quo, HIV elimination in South Africa is unlikely within a 50-year time scale.
© The Author 2016. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HIV; South Africa; acquired immunodeficiency syndrome; agent-based models; human immunodeficiency virus; mathematical modeling

Mesh:

Substances:

Year:  2016        PMID: 27416841      PMCID: PMC4967594          DOI: 10.1093/aje/kwv344

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  55 in total

Review 1.  Partner reduction is crucial for balanced "ABC" approach to HIV prevention.

Authors:  James D Shelton; Daniel T Halperin; Vinand Nantulya; Malcolm Potts; Helene D Gayle; King K Holmes
Journal:  BMJ       Date:  2004-04-10

2.  Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Authors:  Quarraisha Abdool Karim; Salim S Abdool Karim; Janet A Frohlich; Anneke C Grobler; Cheryl Baxter; Leila E Mansoor; Ayesha B M Kharsany; Sengeziwe Sibeko; Koleka P Mlisana; Zaheen Omar; Tanuja N Gengiah; Silvia Maarschalk; Natasha Arulappan; Mukelisiwe Mlotshwa; Lynn Morris; Douglas Taylor
Journal:  Science       Date:  2010-07-19       Impact factor: 47.728

3.  Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda.

Authors:  Rebecca Bunnell; John Paul Ekwaru; Peter Solberg; Nafuna Wamai; Winnie Bikaako-Kajura; Willy Were; Alex Coutinho; Cheryl Liechty; Elizabeth Madraa; George Rutherford; Jonathan Mermin
Journal:  AIDS       Date:  2006-01-02       Impact factor: 4.177

4.  Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs.

Authors:  D R Holtgrave; S D Pinkerton
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-09-01

5.  Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.

Authors:  Michael C Thigpen; Poloko M Kebaabetswe; Lynn A Paxton; Dawn K Smith; Charles E Rose; Tebogo M Segolodi; Faith L Henderson; Sonal R Pathak; Fatma A Soud; Kata L Chillag; Rodreck Mutanhaurwa; Lovemore Ian Chirwa; Michael Kasonde; Daniel Abebe; Evans Buliva; Roman J Gvetadze; Sandra Johnson; Thom Sukalac; Vasavi T Thomas; Clyde Hart; Jeffrey A Johnson; C Kevin Malotte; Craig W Hendrix; John T Brooks
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

6.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

Authors:  Jared M Baeten; Deborah Donnell; Patrick Ndase; Nelly R Mugo; James D Campbell; Jonathan Wangisi; Jordan W Tappero; Elizabeth A Bukusi; Craig R Cohen; Elly Katabira; Allan Ronald; Elioda Tumwesigye; Edwin Were; Kenneth H Fife; James Kiarie; Carey Farquhar; Grace John-Stewart; Aloysious Kakia; Josephine Odoyo; Akasiima Mucunguzi; Edith Nakku-Joloba; Rogers Twesigye; Kenneth Ngure; Cosmas Apaka; Harrison Tamooh; Fridah Gabona; Andrew Mujugira; Dana Panteleeff; Katherine K Thomas; Lara Kidoguchi; Meighan Krows; Jennifer Revall; Susan Morrison; Harald Haugen; Mira Emmanuel-Ogier; Lisa Ondrejcek; Robert W Coombs; Lisa Frenkel; Craig Hendrix; Namandjé N Bumpus; David Bangsberg; Jessica E Haberer; Wendy S Stevens; Jairam R Lingappa; Connie Celum
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

7.  Dramatic increase in HIV prevalence after scale-up of antiretroviral treatment.

Authors:  Jaffer Zaidi; Erofili Grapsa; Frank Tanser; Marie-Louise Newell; Till Bärnighausen
Journal:  AIDS       Date:  2013-09-10       Impact factor: 4.177

Review 8.  HIV treatment as prevention: considerations in the design, conduct, and analysis of cluster randomized controlled trials of combination HIV prevention.

Authors:  Marie-Claude Boily; Benoît Mâsse; Ramzi Alsallaq; Nancy S Padian; Jeffrey W Eaton; Juan F Vesga; Timothy B Hallett
Journal:  PLoS Med       Date:  2012-07-10       Impact factor: 11.069

9.  Development, calibration and performance of an HIV transmission model incorporating natural history and behavioral patterns: application in South Africa.

Authors:  Alethea W McCormick; Nadia N Abuelezam; Erin R Rhode; Taige Hou; Rochelle P Walensky; Pamela P Pei; Jessica E Becker; Madeline A DiLorenzo; Elena Losina; Kenneth A Freedberg; Marc Lipsitch; George R Seage
Journal:  PLoS One       Date:  2014-05-27       Impact factor: 3.240

Review 10.  Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review.

Authors:  Sydney Rosen; Matthew P Fox; Christopher J Gill
Journal:  PLoS Med       Date:  2007-10-16       Impact factor: 11.069

View more
  9 in total

1.  Daily Vaginal Swabs and Mobile Phone Sex Report for Assessing HIV Virion Exposure Prospectively Among a Cohort of Young Sexually Active Women in South Africa (HVTN 915).

Authors:  Maria P Lemos; Erica Lazarus; Abby Isaacs; Janan Dietrich; Cecilia Morgan; Yunda Huang; Doug Grove; Michele Andrasik; Fatima Laher; John Hural; Eva Chung; Joan Dragavon; Adrian Puren; Reena K Gulati; Robert Coombs; Margaret Juliana McElrath; Glenda Gray; James G Kublin
Journal:  J Acquir Immune Defic Syndr       Date:  2019-06-01       Impact factor: 3.731

2.  Thinking clearly about social aspects of infectious disease transmission.

Authors:  Caroline Buckee; Abdisalan Noor; Lisa Sattenspiel
Journal:  Nature       Date:  2021-06-30       Impact factor: 49.962

3.  Betting on the fastest horse: Using computer simulation to design a combination HIV intervention for future projects in Maharashtra, India.

Authors:  Kelly V Ruggles; Anik R Patel; Stephen Schensul; Jean Schensul; Kimberly Nucifora; Qinlian Zhou; Kendall Bryant; R Scott Braithwaite
Journal:  PLoS One       Date:  2017-09-05       Impact factor: 3.240

4.  Low HIV incidence in pregnant and postpartum women receiving a community-based combination HIV prevention intervention in a high HIV incidence setting in South Africa.

Authors:  Geoffrey Fatti; Najma Shaikh; Debra Jackson; Ameena Goga; Jean B Nachega; Brian Eley; Ashraf Grimwood
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

5.  Combined interventions to reduce HIV incidence in KwaZulu-Natal: a modelling study.

Authors:  Stéphanie Blaizot; Helena Huerga; Benjamin Riche; Tom Ellman; Amir Shroufi; Jean-François Etard; René Ecochard
Journal:  BMC Infect Dis       Date:  2017-07-26       Impact factor: 3.090

6.  Mathematical modelling to inform 'treat all' implementation in sub-Saharan Africa: a scoping review.

Authors:  April D Kimmel; Rose S Bono; Olivia Keiser; Jean D Sinayobye; Janne Estill; Deo Mujwara; Olga Tymejczyk; Denis Nash
Journal:  J Virus Erad       Date:  2018-11-15

Review 7.  Sexually transmitted infections and HIV in the era of antiretroviral treatment and prevention: the biologic basis for epidemiologic synergy.

Authors:  Myron S Cohen; Olivia D Council; Jane S Chen
Journal:  J Int AIDS Soc       Date:  2019-08       Impact factor: 5.396

8.  Traditional health practitioners' management of HIV/AIDS in rural South Africa in the era of widespread antiretroviral therapy.

Authors:  Thembelihle Zuma; Daniel Wight; Tamsen Rochat; Mosa Moshabela
Journal:  Glob Health Action       Date:  2017       Impact factor: 2.640

9.  Impact of the test and treat policy on delays in antiretroviral therapy initiation among adult HIV positive patients from six clinics in Johannesburg, South Africa: results from a prospective cohort study.

Authors:  Dorina Onoya; Tembeka Sineke; Cheryl Hendrickson; Idah Mokhele; Mhairi Maskew; Lawrence C Long; Matthew Fox
Journal:  BMJ Open       Date:  2020-03-25       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.